HERBALIFE LTD
HLFNYSE🏆 #2291 by market capEarnings Nov 4US Equity
$12.44▼ $0.16 (−1.27%)
🌙 After hours$12.50▲ 0.48%Regular close · extended-hours price shownTrack HLF
Get earnings, price moves & breaking news on Telegram
24h▼ 1.3%
7d▲ 3.8%
14d▲ 5.2%
30d▲ 13.2%
ytd▼ 3.6%
1y▲ 47.3%
🏦Market Cap
$1.29B
Small Cap
📈Revenue Growth (YoY)
+0.9%
Slowing
📊Gross Margin
75.9%
High
💵FCF Margin
8.2%
Moderate
⚖️P/S Ratio
0.3x
Cheap
Otter Score
68
Fair
HERBALIFE LTD
HLFAnalyst Ratings
Price
$12.44
Total
26
Raised
6
Lowered
7
Avg PT
$19.00
H / L
$21 / $17
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Reiterated | Buy | 2026-08-07 | $36.00 | +189.40% |
RBC Capital | Reiterated | Sector Perform | 2026-04-28 | — | — |
Mizuho | Reiterated | Neutral | 2026-03-30 | — | — |
Argus Research | Upgraded | Hold → Buy | 2025-11-26 | $15.00 | +20.60% |
DA Davidson | Upgraded | Neutral → Buy | 2025-03-21 | $14.00 | +12.50% |
B. Riley Securities | Reiterated | Buy | 2024-10-31 | — | — |
B of A Securities | Reiterated | Underperform | 2024-03-21 | — | — |
Jefferies | Upgraded | Hold → Buy | 2022-07-12 | — | — |
Citi | Reiterated | Buy | 2019-08-02 | — | — |
Argus | Downgraded | Buy → Hold | 2018-05-05 | — | — |
Tigress Financial | Reiterated | Buy | 2017-04-24 | — | — |
Pivotal Research | Reiterated | Buy | 2015-08-27 | — | — |
Canaccord Genuity | Reiterated | Buy | 2015-05-06 | — | — |
Barclays | Reiterated | Overweight | 2015-01-15 | — | — |
Buckingham Research | Downgraded | Buy → Neutral | 2015-01-05 | — | — |
BTIG Research | Reiterated | Buy | 2014-11-19 | — | — |
SunTrust Robinson Humphrey | Downgraded | Buy → Neutral | 2014-11-03 | — | — |
Argus Capital | Downgraded | Buy → Hold | 2014-03-21 | — | — |
S&P Capital IQ | Upgraded | Sell → Hold | 2014-01-23 | — | — |
Wedbush | Reiterated | Outperform | 2013-12-27 | — | — |
Makor Capital | Downgraded | Buy → Hold | 2013-07-24 | — | — |
D.A. Davidson | Upgraded | Neutral → Buy | 2013-04-12 | $14.00 | +12.50% |
Janney Montgomery Scott | Downgraded | Buy → Neutral | 2013-01-11 | — | — |
Janney Capital | Downgraded | Buy → Neutral | 2013-01-11 | — | — |
Caris & Co. | Upgraded | Average → Buy | 2012-05-17 | — | — |
Auriga | Reiterated | Hold | 2012-02-23 | — | — |
Institution
Citigroup
Reiterated · Buy · 2026-08-07
$36.00
+189.40%
RBC Capital
Reiterated · Sector Perform · 2026-04-28
—
—
Mizuho
Reiterated · Neutral · 2026-03-30
—
—
Argus Research
Upgraded · Hold → Buy · 2025-11-26
$15.00
+20.60%
DA Davidson
Upgraded · Neutral → Buy · 2025-03-21
$14.00
+12.50%
B. Riley Securities
Reiterated · Buy · 2024-10-31
—
—
B of A Securities
Reiterated · Underperform · 2024-03-21
—
—
Jefferies
Upgraded · Hold → Buy · 2022-07-12
—
—
Citi
Reiterated · Buy · 2019-08-02
—
—
Argus
Downgraded · Buy → Hold · 2018-05-05
—
—
Tigress Financial
Reiterated · Buy · 2017-04-24
—
—
Pivotal Research
Reiterated · Buy · 2015-08-27
—
—
Canaccord Genuity
Reiterated · Buy · 2015-05-06
—
—
Barclays
Reiterated · Overweight · 2015-01-15
—
—
Buckingham Research
Downgraded · Buy → Neutral · 2015-01-05
—
—
BTIG Research
Reiterated · Buy · 2014-11-19
—
—
SunTrust Robinson Humphrey
Downgraded · Buy → Neutral · 2014-11-03
—
—
Argus Capital
Downgraded · Buy → Hold · 2014-03-21
—
—
S&P Capital IQ
Upgraded · Sell → Hold · 2014-01-23
—
—
Wedbush
Reiterated · Outperform · 2013-12-27
—
—
Makor Capital
Downgraded · Buy → Hold · 2013-07-24
—
—
D.A. Davidson
Upgraded · Neutral → Buy · 2013-04-12
$14.00
+12.50%
Janney Montgomery Scott
Downgraded · Buy → Neutral · 2013-01-11
—
—
Janney Capital
Downgraded · Buy → Neutral · 2013-01-11
—
—
Caris & Co.
Upgraded · Average → Buy · 2012-05-17
—
—
Auriga
Reiterated · Hold · 2012-02-23
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space